8 result(s) for Phase I Clinical Trials
| PI Name | Protocol # | Title |
|---|---|---|
| Neil Gross | IRB00005265 | Phase I Trial of Intratumoral Administration of HF10, a Replication-Competent Herpes Simplex Virus Type 1, in Patients with Refractory Head and Neck Cancer or Solid Tumors with Cutaneous and/or Superficial Lesions |
| Stephen Spurgeon | IRB00006550 | A Phase I Study of GNKG168 Administered by Intravenous Infusion in Patients with Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) or B-Cell Lymphoma |
| Matthew Taylor | IRB00006867 | A Phase 1 Study of Oral Carboxyamidotriazole Orotate (CTO) Titrated as a Single Agent in Patients with Advanced or Metastatic Solid Tumors and Titrated in Combination Therapy with Temodar® in Patients with Glioblastom Multiforme |
| Andy Chen | IRB00007406 | An Open-Label, Multicenter, Phase I Trial of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDT2980S in Combination with Rituximab in Patients with Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphoma |
| Tomasz Beer | IRB00007590 | A Phase 1 Study of MLN8237, an Aurora A Kinase Inhibitor, in Patients With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen |
| Matthew Taylor | IRB00007677 | A Phase Ib Open-Label study of the Safety and Clinical Activity of Crizotinib (PF-02341066) in Tumors with Genetic Events Involving the Anaplastic Lymphoma Kinase (ALK) Gene Locus |
| Emma Scott | IRB00008296 | PHASE I INFUSIONAL CYCLOPHOSPHAMIDE AND PULSE DEXAMETHASONE WITH RAPAMYCIN AND HYDROXYCHLOROQUINE IN PATIENTS WITH RELAPSED OR REFRACTORY MYELOMA |
| Matthew Taylor | IRB00008710 | An Open-Label, Phase Ib Dose Escalation Trial of Oral Combination Therapy with MSC1936369B and SAR245409 in Subjects with Locally Advanced or Metastatic Solid Tumors |
You may qualify for additional trials within our Phase 1 Program